Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leukocyte-Poor vs Leukocyte-Rich PRP in Knee Osteoarthritis
NCT07857954Completed
- Sponsor
- St Catherine Specialty Hospital
- Start
- Nov 2023
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Randomised, single-blind trial of platelet-rich plasma in knee osteoarthritis (OA) (2 arms), sponsored by St Catherine Specialty Hospital. Primary endpoints: Knee injury and Osteoarthritis Outcome Score at 12 months, Visual Analogue Scale at 12 months and 1 more. Started Nov 2023; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07857954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07857954.